The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers
- 1 October 1984
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 3 (5) , 468-470
- https://doi.org/10.1007/bf02017377
Abstract
The plasma pharmacokinetics of imipenem, a beta-lactam antibiotic of the new class of carbapenems, was evaluated by administering 1 g imipenem plus 1 g of the dehydropeptidase inhibitor cilastatin to six healthy male volunteers over 30 min. Subsequently intensive plasma sampling was done for 5.5 h. The volume of distribution of the central compartment was 0.16±0.04 1/kg; the volume of distribution (area) was 0.28±0.07 1/kg; the volume of distribution (steady state) was 0.23±0.03 1/kg. The mean plasma clearance was 10.1±1.0 l/h/1.73 m2. Model-independent analysis showed excellent agreement with these values. The terminal excretion half-life was short (1.3±0.4 h). For approximately 6 h after administration, the observed plasma levels were above those required to inhibit most nosocomial pathogens in vitro.This publication has 8 references indexed in Scilit:
- Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stabilityJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Urinary Recovery of N -Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N -Formimidoyl Thienamycin Dehydropeptidase InhibitorsAntimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humansAntimicrobial Agents and Chemotherapy, 1983
- PharmacokineticsPublished by Taylor & Francis ,1982
- In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistanceAntimicrobial Agents and Chemotherapy, 1981
- In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus sppAntimicrobial Agents and Chemotherapy, 1981
- In vitro activity of N-formimidoyl thienamycin (MK0787)Antimicrobial Agents and Chemotherapy, 1980
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979